One of the most relevant findings of our present study is that BAFF-deficient mice are protected from the development of NASH and the progression of fibrosis (Figure 3), which may contribute to the higher liver weight in BAFF−/− mice compared to that in WT mice (Figure 1b). Here, TNFSF13B is linked to metabolic dysfunction-associated steatohepatitis.